In conclusion, this multinational investigation characterizes the largest cohort of patients with molecularly confirmed CRB1 retinopathy as of this writing, identifies novel CRB1 variants, and delineates genotype-phenotype correlations. Here, CRB1 is linked to retinal disorder.